Company Description
Jazz Pharmaceuticals wants to paint the town with successful treatments for niche psychiatric and neurological conditions. The company has several...
Key Jazz Pharmaceuticals Financials
| Company Type | Public - NASDAQ (GM): JAZZ Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $65.3 |
| 2006 Employees | 185 |
Latest Jazz Pharmaceuticals Jobs jobs by Indeed
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs....
Read more about Jazz Pharmaceuticals's competition across multiple industries
Top Jazz Pharmaceuticals Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Jazz Pharmaceuticals Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Executive Chairman | Bruce C. Cozadd | Network | E-mail |
| CEO and Director | Samuel R. Saks | Network | E-mail |
| EVP and CFO | Matthew K. (Matt) Fust | Network | E-mail |
More Jazz Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Jazz Pharmaceuticals News
- Research results from M.M. Foreman and colleagues update understanding of depression [Pain & Central Nervous System Week] (23 Jun 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (12 Jun 2008 23:00:00 EDT)
- Briefing.com: Hourly In Play (R) - 22:00 ET [Briefing.com] (12 Jun 2008 22:00:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.